Rheologics Technologies, Inc. (PINKSHEETS: RTGI) (“Rheologics”), the leader in the study of blood viscosity and its relationship to cardiovascular and vascular diseases is pleased to announce that HeartWare Limited (ASX: HTW) (“HeartWare”), a medical device company headquartered in Sydney, Australia, has acquired a Rheolog™ blood viscometer.
